| Product Name | MF | CAS | Details |
|---|
| CPPHA | C22H15ClN2O4 | 693288-97-0 | Details |
| 1-(Piperidin-4-yl)cyclobutan-1-ol | C9H17NO | 1895467-61-4 | Details |
| 5-Amino-1,3-dimethyl-1H-pyrazole-4-carboxylic acid | C6H9N3O2 | 1342150-56-4 | Details |
| Sodium 2-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]acetate | C11H9ClNNaO2S | 1209660-82-1 | Details |
| 4-Aminopicolinamide | C6H7N3O | 100137-47-1 | Details |
| ACCN3 Blocking Peptide | Details |
| KCNRG Blocking Peptide | Details |
| 2-acetyl-5,5-dioxo-5λ6-thia-2-azaspiro[3.4]octane-8-carboxylate lithium | 2344680-34-6 | Details |
| b-D-Galactopyranosyl-(1,4)-O-b-D-glucopyranosyl-(1,4)-D-glucose | Details |
| 5-Methyl-4,5,6,7-tetrahydrobenzo[d]isoxazole-3-carboxylic acid | C9H11NO3 | 832737-91-4 | Details |
| beta-Lipotropin (1-10), porcine | C42H66N10O15 | Details |
| 2-Cyclopropylquinazoline-4-thiol | C11H10N2S | 604754-96-3 | Details |
| Ethyl 2-Ethoxy-1-((2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate | C27H24N4O5 | 1403474-70-3 | Details |
| tert-Butyl [bis(cyanomethyl)carbamoyl]formate | C10H13N3O3 | 1803595-17-6 | Details |
| 2-(4-Fluorophenyl)cyclopropanecarboxylic acid | C10H9FO2 | 879324-64-8 | Details |
| 5Fam-LRRFSTAPFAFIDINDVINF-NH2 | Details |
| BI 224436 | C27H26N2O4 | 1155419-89-8 | Details |
| Potassiumtetrachloroaurate(III) | AuCl4K | 13682-61-6 | Details |
| 1,8-Naphthyridine-3-carbonitrile | C9H5N3 | 1142927-39-6 | Details |
| 1-(5-Aminopyridin-2-yl)-3-ethyl-4,5-dihydro-1H-pyrazol-5-one | C10H12N4O | 1178187-90-0 | Details |
| 4-Phenyl-3-(trifluoromethyl)aniline | C13H10F3N | 641570-82-3 | Details |
| 2-(2-Hydroxyphenyl)-4H-1,3-benzoxazin-4-one | C14H9NO3 | 1218-69-5 | Details |
| 4-Oxo-1-(2-pyridinyl)cyclohexanecarbonitrile | C12H12N2O | 80139-11-3 | Details |
| [(1-Ethylpyrrolidin-2-yl)methyl](methyl)amine | C8H18N2 | 60923-27-5 | Details |
| 4-(4-Formyl-1-methyl-1H-pyrazol-3-yl)benzonitrile | C12H9N3O | 1152508-50-3 | Details |
| 2'-Hydroxychalcone | C15H12O2 | 1214-47-7 | Details |
| Methyl 2-amino-2-(4-methoxyphenyl)propanoate | C11H15NO3 | 1178066-89-1 | Details |
| 2-amino-1-(1-aza-2-(4-butoxyphenyl)vinyl)ethene-1,2-dicarbonitrile | C15H16N4O | 497060-47-6 | Details |
| Macrocarpal C | C28H38O5 | 142628-53-3 | Details |
| TMPyP4 tosylate | C72H66N8O12S4 | 36951-72-1 | Details |
| Met-Enkephalin-Arg acetate salt | C33H47N9O8S | 76310-14-0 | Details |
| 2-Methylresorcinol, technical | C7H8O2 | 608-25-3 | Details |
| A1 Glycan, 2-AB labelled | Details |
| 1-(1-Phenylpropan-2-yl)-1H-pyrrole-2-carboxylic acid | C14H15NO2 | 1432680-68-6 | Details |
| Picolinic acid ethyl ester | C8H9NO2 | 2524-52-9 | Details |
| 6-chloro-2-ethylimidazo[1,2-a]pyridine-3-carboxylic acid | C10H9ClN2O2 | 1216142-18-5 | Details |
| 5-(tert-Butylamino)pyridine-2-carbonitrile | C10H13N3 | 160017-07-2 | Details |
| HNRNPC antibody | Details |
| P2RY11 antibody | Details |
| 3-Butyl-1,10-ethylidenealloxazinium chloride | 1652598-47-4 | Details |
| 5-Ethyl-10-methoxy-5H-dibenz[b,f]azepine | C17H17NO | 15882-79-8 | Details |
| MED13L antibody | Details |
| N-(4-Bromophenyl)-3-nitropyridin-2-amine | C11H8BrN3O2 | 78750-60-4 | Details |
| tert-Butyl N-[(3R)-1-hydroxy-4-methylpentan-3-yl]carbamate | C11H23NO3 | 285124-33-6 | Details |
| 6-Hydroxy-3,3-dimethyl-1,2,3,4-tetrahydronaphthalen-1-one | C12H14O2 | 59258-05-8 | Details |
| EPHA4 antibody (Tyr596) | Details |
| Carboxy-PEG2-sulfonic acid | C7H14O7S | 1817735-45-7 | Details |
| Methyl 2-(2-acetylphenoxy)acetate | C11H12O4 | 77956-92-4 | Details |
| ACAA1 antibody | Details |
| Methyl [(4-amino-3,5-dichloro-6-fluoro-2-pyridinyl)oxy]acetate | C8H7Cl2FN2O3 | 69184-17-4 | Details |
| 2-Chloro-N-[2-(3-methoxyphenoxy)ethyl]acetamide | C11H14ClNO3 | 1226115-30-5 | Details |
| TPH1 antibody (Ser260) | Details |
| 4,4-Difluoro-3-methyloxolane-3-carboxylic acid | C6H8F2O3 | 1782346-79-5 | Details |
| 1-Methyl-5-oxo-1H,4H,5H,6H,7H-imidazo[4,5-b]pyridine-7-carboxylic acid | C8H9N3O3 | 1864072-66-1 | Details |
| NUDC Blocking Peptide | Details |
| 2,6-Dimethoxybenzaldoxime | C9H11NO3 | 174966-94-0 | Details |
| 3-Methyl-2-benzothiazolinone hydrazone hydrochloride monohydrate | C8H9N3S.ClH.H2O | 38894-11-0 | Details |
| tert-Butyl N-[(tert-butoxy)carbonyl]-N-[6-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazin-2-yl]carbamate | C20H32BN3O6 | 1400668-06-5 | Details |
| 3-Cyclopentylpropane-1-sulfonyl chloride | C8H15ClO2S | 1502152-14-8 | Details |
| Dechloroloxapine phosphate | C18H19N3O | 2058-53-9 | Details |
| 4-Bromo-3-chloro-2-nitroaniline | C6H4BrClN2O2 | 1000573-99-8 | Details |
| 3-Acetyl-4-hydroxy-5,6-dimethoxy-1,2-dihydropyridin-2-one | C9H11NO5 | 1231944-64-1 | Details |
| [2-(3,4-Dimethoxyphenyl)ethyl][(1-methyl-1H-pyrazol-4-yl)methyl]amine | C15H21N3O2 | 1006340-53-9 | Details |
| 3-(2,2-Dimethylcyclopropyl)propanoic acid | C8H14O2 | 124201-52-1 | Details |
| Ethyl 2-(5-amino-1H-indol-1-yl)acetate hydrochloride | C12H15ClN2O2 | 1221722-73-1 | Details |
| 2α,9α,11-Trihydroxy-6-oxodrim-7-ene | C15H24O4 | 1175543-03-9 | Details |
| FBXO32 antibody | Details |
| TMEM123 Blocking Peptide | Details |
| NUCB1 antibody | Details |
| rac-1,2-Dimethyl (1R,2S)-4-oxocyclopentane-1,2-dicarboxylate | C9H12O5 | 28269-02-5 | Details |
| 3-(2-Oxo-2,3-dihydro-1H-imidazol-1-yl)benzoic acid | C10H8N2O3 | 939999-26-5 | Details |
| 2-(2-Methylpropyl)-1,3-thiazole-5-carboxylic acid | C8H11NO2S | 1152614-38-4 | Details |
| 2-Bromo-2-cyclopropylacetonitrile | C5H6BrN | 1551295-22-7 | Details |
| 1-Methyl-7-(trifluoromethyl)-1,2,3,4-tetrahydroquinoxalin-2-one | C10H9F3N2O | 1783769-47-0 | Details |
| 1-Acetyl-2-methylindoline-5-sulphonyl chloride | C11H12ClNO3S | 841275-78-3 | Details |
| ACBD7 antibody | Details |
| Ac-Rpf-NH2 | Details |
| [Asu1,6]-Oxytocin | C45H69N11O12 | 14317-68-1 | Details |
| Cyclopropyl(3,4-dimethylphenyl)methanone | C12H14O | 38675-78-4 | Details |
| 2-Fluoro-6-nitrobenzene-1-sulfonamide | C6H5FN2O4S | 1210309-74-2 | Details |
| 2-(4-chlorophenylthio)-1-(4-phenylpiperazinyl)propan-1-one | C19H21ClN2OS | 428476-73-7 | Details |
| Ethyl 2-acetyl-4-(4-chlorophenyl)-4-oxobutanoate | C14H15ClO4 | 111787-82-7 | Details |
| 5-Amino-1,4-dimethyl-1H-pyrazole-3-carboxylic acid | C6H9N3O2 | 1368364-31-1 | Details |
| N-[6-Amino-1-(2-methylpropyl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl]-N-butyl-2-chloroacetamide | C14H23ClN4O3 | 561009-03-8 | Details |
| Rhodizonic acid dihydrate | C6H2O6 | 118-76-3 | Details |
| Recombinant Mouse FGF-8c | Details |
| Goat anti Mouse IgG (Fab'2) (rhodamine) | Details |
| H-TVLAVFGK^-OH | Details |
| 4-(2-pyridyl)piperazinyl 2-thienyl ketone | C14H15N3OS | Details |
| 3-Amino-1-(1-ethyl-1H-pyrazol-5-yl)piperidin-2-one | C10H16N4O | 1803580-59-7 | Details |
| 3-Ethynyl-5-fluorobenzoic acid | C9H5FO2 | 1866020-80-5 | Details |
| (1-Ethyl-pyrrolidin-2-ylmethyl)-pyridin-4-ylmethyl-amine | C13H21N3 | 726162-94-3 | Details |
| 4-(3-Fluorophenyl)-2-(piperidin-4-yl)pyrimidine hydrochloride | C15H17ClFN3 | 2059949-59-4 | Details |
| Darutoside | C26H44O8 | 59219-65-7 | Details |
| Influenza A Virus Nucleoprotein, Recombinant | Details |
| Ac-Kpr-NH2 | Details |
| Goat anti Rat IgG (H + L) (HRP) | Details |
| 4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]-butanoic acid | C10H19NO5 | 18679-90-8 | Details |
| MK 0731 | C25H28F3N3O2 | 845256-65-7 | Details |
| Human Pancreas Tissue Lysate | Details |
| Product Total： Product Page： | ||||
| 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 | ||||